CL Colgate-Palmolive Company

NYSE
$98.85

Colgate-Palmolive Company (CL) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Subdued Selling ran below CL's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
4
5 transactions
Purchases
$0
0 shares
Sales
$7.6M
77,484 shares
Net activity
-$7.6M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $7.6M 5 transactions · 77,484 shares

Largest single sale: $2.3M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Wallace Noel R. Chairman, President & CEO Sell 20,000 $100.26 $2.0M 359,700 −5.3% of holding
NORRINGTON LORRIE M Director Sell 4,170 $99.31 $414.1K 43,383 −8.8% of holding
Hazlin John Chief Growth Officer Sell 23,376 $99.15 $2.3M 27,021 −46.4% of holding
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin Sell 19,938 $98.74 $2.0M 9,111 −68.6% of holding
Tsourapas Panagiotis COO, CD, EMEA, APac, Skin Sell 10,000 $92.05 $920.5K 64,901 −13.4% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.